Genotyping polymorphisms in the 5-HT2AR receptor or other relevant molecular targets in the psychedelic response pathway may help reduce variability in outcome parameters, identify underlying biological substrates, or stratify patients in future studies.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (1)

• 5-HT2A receptor concept